Chinese clinical practice guideline on the management of ulcerative colitis (2023, Xi′an)
吴开春 1陈旻湖 2钱家鸣 3周静 古敏怡
扫码查看
点击上方二维码区域，可以放大扫码查看
作者信息
1. 空军军医大学西京医院消化病医院，西安 710032
2. 中山大学附属第一医院消化内科，广州 510080
3. 中国医学科学院 北京协和医学院 北京协和医院消化内科，北京 100730
折叠
摘要
溃疡性结肠炎（UC）病情反复持久，涉及多个学科，规范化诊疗对提高UC的疗效及改善预后非常重要。近年来我国在UC的基础及临床研究取得诸多进展，加上新的诊疗理念、新的治疗药物不断应用于临床，有必要更新UC诊疗共识意见，为广大临床工作者提供基于最新循证依据的诊治指南。本指南是由中华医学会消化病学分会炎症性肠病学组结合国外最新共识、国内研究成果和实际情况，在2018年版炎症性肠病诊断和治疗共识意见基础上进行修订。本指南的制定旨在反映当前UC临床诊治的最新理念及研究成果，为UC的临床诊治提供规范化指导意见。 Ulcerative colitis (UC) is a chronic and prolonged condition spanning multiple disciplines. Standardized diagnostics and treatment are paramount for enhancing the medical efficacy and improving the prognosis of UC. In the last a couple of years, substantial progress has been achieved in both basic and clinical research on UC in our country. The integration of novel diagnostic and therapeutic paradigms, new treatment modalities, have necessitated the update of consensus on UC management, offering imperative, evidence-based guidelines for health providers. This guideline, collaboratively developed by the Inflammatory Bowel Disease Group of Chinese Society of Gastroenterology of Chinese Medical Association, incorporates the latest international consensus, domestic research findings, and practical considerations, as an update based on the 2018 Chinese Consensus on diagnosis and treatment in inflammatory bowel disease. The formulation of this guideline aims to reflect the latest concepts and research findings in the clinical diagnosis and treatment of UC, providing standardized guidance for the clinical management of UC.
Abstract
Ulcerative colitis (UC) is a chronic and prolonged condition spanning multiple disciplines. Standardized diagnostics and treatment are paramount for enhancing the medical efficacy and improving the prognosis of UC. In the last a couple of years, substantial progress has been achieved in both basic and clinical research on UC in our country. The integration of novel diagnostic and therapeutic paradigms, new treatment modalities, have necessitated the update of consensus on UC management, offering imperative, evidence-based guidelines for health providers. This guideline, collaboratively developed by the Inflammatory Bowel Disease Group of Chinese Society of Gastroenterology of Chinese Medical Association, incorporates the latest international consensus, domestic research findings, and practical considerations, as an update based on the 2018 Chinese Consensus on diagnosis and treatment in inflammatory bowel disease. The formulation of this guideline aims to reflect the latest concepts and research findings in the clinical diagnosis and treatment of UC, providing standardized guidance for the clinical management of UC.
万方数据